Our mission and vision
Read more about BSGCT and gene and cell therapy in the UK.
Uta Griesenbach and Rafael J. Yáñez-Muñoz, 'The British Society for Gene and Cell Therapy', Human Gene Therapy, Oct 2021, 983-985.
We aim to support progress & translation of gene & cell therapies.
We want to see a world where gene and cell therapies are mainstream.
BSGCT will facilitate this progress by:
Promoting communication and the free flow of information between scientists in academia and industry, leading to better collaborations and the sharing of knowledge and resources.
Providing a forum for specialised scientific debate in the field of cell- and gene-based treatments, particularly to enhance the education of younger scientists and clinicians.
Supporting and promoting early career researchers in all aspects of their professional development.
Improving the interaction between scientists and clinicians, to enhance thorough science-led and ethical evaluation of new technologies in the clinic.
Improving public awareness and providing an informed and responsible voice for science in this field.
Improving the productivity of gene and cell therapy research in the UK, expediting technology transfer from the laboratory for clinical study as soon as it is appropriate.
Developing strong links with donors and funding bodies, aiming to improve the scientific infrastructure that already exists in the UK.